368 related articles for article (PubMed ID: 22268294)
1. Role of TGF-β and the tumor microenvironment during mammary tumorigenesis.
Taylor MA; Lee YH; Schiemann WP
Gene Expr; 2011; 15(3):117-32. PubMed ID: 22268294
[TBL] [Abstract][Full Text] [Related]
2. Noncanonical TGF-β signaling during mammary tumorigenesis.
Parvani JG; Taylor MA; Schiemann WP
J Mammary Gland Biol Neoplasia; 2011 Jun; 16(2):127-46. PubMed ID: 21448580
[TBL] [Abstract][Full Text] [Related]
3. The pathophysiology of epithelial-mesenchymal transition induced by transforming growth factor-beta in normal and malignant mammary epithelial cells.
Taylor MA; Parvani JG; Schiemann WP
J Mammary Gland Biol Neoplasia; 2010 Jun; 15(2):169-90. PubMed ID: 20467795
[TBL] [Abstract][Full Text] [Related]
4. The Cain and Abl of epithelial-mesenchymal transition and transforming growth factor-β in mammary epithelial cells.
Allington TM; Schiemann WP
Cells Tissues Organs; 2011; 193(1-2):98-113. PubMed ID: 21051857
[TBL] [Abstract][Full Text] [Related]
5. Fibulin-5 initiates epithelial-mesenchymal transition (EMT) and enhances EMT induced by TGF-beta in mammary epithelial cells via a MMP-dependent mechanism.
Lee YH; Albig AR; Regner M; Schiemann BJ; Schiemann WP
Carcinogenesis; 2008 Dec; 29(12):2243-51. PubMed ID: 18713838
[TBL] [Abstract][Full Text] [Related]
6. Beta3 integrin and Src facilitate transforming growth factor-beta mediated induction of epithelial-mesenchymal transition in mammary epithelial cells.
Galliher AJ; Schiemann WP
Breast Cancer Res; 2006; 8(4):R42. PubMed ID: 16859511
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic targeting of the focal adhesion complex prevents oncogenic TGF-beta signaling and metastasis.
Wendt MK; Schiemann WP
Breast Cancer Res; 2009; 11(5):R68. PubMed ID: 19740433
[TBL] [Abstract][Full Text] [Related]
8. The TGF-beta paradox in human cancer: an update.
Tian M; Schiemann WP
Future Oncol; 2009 Mar; 5(2):259-71. PubMed ID: 19284383
[TBL] [Abstract][Full Text] [Related]
9. The use of cystatin C to inhibit epithelial-mesenchymal transition and morphological transformation stimulated by transforming growth factor-beta.
Sokol JP; Neil JR; Schiemann BJ; Schiemann WP
Breast Cancer Res; 2005; 7(5):R844-53. PubMed ID: 16168131
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor-beta signaling-deficient fibroblasts enhance hepatocyte growth factor signaling in mammary carcinoma cells to promote scattering and invasion.
Cheng N; Chytil A; Shyr Y; Joly A; Moses HL
Mol Cancer Res; 2008 Oct; 6(10):1521-33. PubMed ID: 18922968
[TBL] [Abstract][Full Text] [Related]
11. Lysyl oxidase contributes to mechanotransduction-mediated regulation of transforming growth factor-β signaling in breast cancer cells.
Taylor MA; Amin JD; Kirschmann DA; Schiemann WP
Neoplasia; 2011 May; 13(5):406-18. PubMed ID: 21532881
[TBL] [Abstract][Full Text] [Related]
12. The Six1 homeoprotein induces human mammary carcinoma cells to undergo epithelial-mesenchymal transition and metastasis in mice through increasing TGF-beta signaling.
Micalizzi DS; Christensen KL; Jedlicka P; Coletta RD; Barón AE; Harrell JC; Horwitz KB; Billheimer D; Heichman KA; Welm AL; Schiemann WP; Ford HL
J Clin Invest; 2009 Sep; 119(9):2678-90. PubMed ID: 19726885
[TBL] [Abstract][Full Text] [Related]
13. p130Cas is required for mammary tumor growth and transforming growth factor-beta-mediated metastasis through regulation of Smad2/3 activity.
Wendt MK; Smith JA; Schiemann WP
J Biol Chem; 2009 Dec; 284(49):34145-56. PubMed ID: 19822523
[TBL] [Abstract][Full Text] [Related]
14. TGF-β-Mediated Epithelial-Mesenchymal Transition and Cancer Metastasis.
Hao Y; Baker D; Ten Dijke P
Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31195692
[TBL] [Abstract][Full Text] [Related]
15. PGE2 receptor EP2 mediates the antagonistic effect of COX-2 on TGF-beta signaling during mammary tumorigenesis.
Tian M; Schiemann WP
FASEB J; 2010 Apr; 24(4):1105-16. PubMed ID: 19897661
[TBL] [Abstract][Full Text] [Related]
16. Deconstructing the mechanisms and consequences of TGF-β-induced EMT during cancer progression.
Wendt MK; Tian M; Schiemann WP
Cell Tissue Res; 2012 Jan; 347(1):85-101. PubMed ID: 21691718
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapeutic Targeting of the Transforming Growth Factor-β Pathway in Breast Cancers.
Lee YH; Schiemann WP
Breast Cancer Manag; 2014; 3(1):73-85. PubMed ID: 25904986
[TBL] [Abstract][Full Text] [Related]
18. Complex role of tumor cell transforming growth factor (TGF)-beta s on breast carcinoma progression.
Koli KM; Arteaga CL
J Mammary Gland Biol Neoplasia; 1996 Oct; 1(4):373-80. PubMed ID: 10887511
[TBL] [Abstract][Full Text] [Related]
19. Effect of conditional knockout of the type II TGF-beta receptor gene in mammary epithelia on mammary gland development and polyomavirus middle T antigen induced tumor formation and metastasis.
Forrester E; Chytil A; Bierie B; Aakre M; Gorska AE; Sharif-Afshar AR; Muller WJ; Moses HL
Cancer Res; 2005 Mar; 65(6):2296-302. PubMed ID: 15781643
[TBL] [Abstract][Full Text] [Related]
20. Ecosystems of invasion and metastasis in mammary morphogenesis and cancer.
Mareel M; Constantino S
Int J Dev Biol; 2011; 55(7-9):671-84. PubMed ID: 22161824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]